Literature DB >> 10673070

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival.

K Endo1, T Terada.   

Abstract

BACKGROUND/AIMS: Members of the CD44 family are transmembrane glycoproteins which act mainly as receptors for hyaluronan. We have examined the expression of CD44s and several CD44v and the relationship between these and hepatocellular carcinoma (HCC) grade, clinicopathological parameters, p53 expression, and patient survival in HCC.
METHODS: Formalin-fixed, paraffin-embedded tissue sections from 107 surgically resected HCC were examined immunohistochemically using a semi-quantitative scoring system to detect the expression of different forms of CD44.
RESULTS: The number of CD44s-positive cases was 36 (34%), CD44v5 52 (49%), CD44v6 29 (27%), CD44v7-8 41 (38%), and CD44v10 26 (24%). Expression of these molecules correlated with high histological grade, being the highest in poorly-differentiated HCC. High CD44v6 expression significantly correlated with the presence of vascular invasion and p53 overexpression. Kaplan-Meier examination of patient survival revealed that HCC patients with positivity of each of these five molecules had a reduced survival rate, and that HCC patients positive for all the five CD44 molecules had worse survival than HCC patients positive for four or less of these CD44 molecules. In multivariate survival analysis, CD44s positivity was an independent factor. However, positivity for one or more CD44 isoforms was the most useful independent factor for overall survival.
CONCLUSION: These results suggest that up-regulation of CD44 isoforms is associated with poorly-differentiated HCC and shortened survival.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673070     DOI: 10.1016/s0168-8278(00)80192-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  58 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

2.  ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.

Authors:  Nuozhou Wang; Ming-Yue Li; Yi Liu; Jianqing Yu; Jianwei Ren; Zhiyuan Zheng; Shanshan Wang; Shucai Yang; Sheng-Li Yang; Li-Ping Liu; Bao-Guang Hu; Charing Cn Chong; Juanita L Merchant; Paul Bs Lai; George Gong Chen
Journal:  Cancer Lett       Date:  2019-12-23       Impact factor: 8.679

Review 3.  Cervical cancer stem cells: opportunities and challenges.

Authors:  Ravindresh Chhabra
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-07       Impact factor: 4.553

4.  Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients.

Authors:  Heng Fong Seow; Wai Kien Yip; Hui Woon Loh; Hairuszah Ithnin; Patricia Por; Mohammad Rohaizak
Journal:  Pathol Oncol Res       Date:  2009-11-01       Impact factor: 3.201

Review 5.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

6.  miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines.

Authors:  Jon C Henry; Jong-Kook Park; Jinmai Jiang; Ji Hye Kim; David M Nagorney; Lewis R Roberts; Soma Banerjee; Thomas D Schmittgen
Journal:  Biochem Biophys Res Commun       Date:  2010-11-03       Impact factor: 3.575

7.  A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma.

Authors:  Tin Oo Khor; Yunus A Gul; Hairuszah Ithnin; Heng Fong Seow
Journal:  Int J Colorectal Dis       Date:  2005-07-22       Impact factor: 2.571

Review 8.  Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Mei Wang
Journal:  World J Hepatol       Date:  2015-01-27

Review 9.  Clinical implications of cancer stem cell biology in hepatocellular carcinoma.

Authors:  Junfang Ji; Xin Wei Wang
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

10.  Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.

Authors:  F Rosso; V Quagliariello; C Tortora; A Di Lazzaro; A Barbarisi; R V Iaffaioli
Journal:  J Mater Sci Mater Med       Date:  2013-03-08       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.